Alternatives
Alternatives to Visipaque 16000 mg/50 mL injection
1 other presentations of Iodixanol 16000 mg/50 mL injection
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Iodixanol), strength (16000 mg/50 mL) and dosage form (injection) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Visipaque 16000 mg/50 mL injectionThis pageIntravascular | GE Healthcare | US FDA | 10 bottles of 50 mL | Do not freeze. Discard any product that is inadvertently frozen, as freezing may compromise the closure integrity of the immediate container. Store VISIPAQUE at controlled room temperature, 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). VISIPAQUE may be stored in a contrast media warmer for up to one month at 37°C (98.6°F). | On request | — | Available on request |
| Iodixanol 16000 mg/50 mL injectionIntravascular | — | US FDA | 10 bottles of 50 mL | Do not freeze. Discard any product that is inadvertently frozen, as freezing may compromise the closure integrity of the immediate container. Store iodixanol injection, USP at controlled room temperature, 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F). Iodixanol injection, USP may be stored in a contrast media warmer for up to one month at 37°C (98.6°F). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Visipaque 16000 mg/50 mL injectionNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.